Beta-O2 Technologies: FDA decision boosts Beta02's artificial pancreas
The Israeli company's device which contains living pancreas cells that automatically secrete insulin into the blood stream could be a boon for diabetics.
Read full article »
Beta-O2 Technologies is a biomedical firm that develops a proprietary implantable bioreactor, the ßAir for patients.
Read more